Defining the pharmacology, safety, and dosing of ?PB-FC? a novel bacterial drug-candidate for reversal of dysbiosis in acute graft-versus-host disease

Font Standard Bold
Login

Project search
Actual Project
Recent projects
Graphics
Login

Research unit

INNOSUISSE

Project number

120.452 IP-LS

Project title

Defining the pharmacology, safety, and dosing of ?PB-FC? a novel bacterial drug-candidate for reversal of dysbiosis in acute graft-versus-host disease

Basic data
Texts
Participants

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Inserted texts

Category	Text
Key words (English)	Life sciences, Pharmaceuticals
Abstract (English)	In this project PharmaBiome?s Functional Consortium (PB-FC) designed for the treatment of gut dysbiosis in acute graft-versus-host disease (aGvHD) patients will be tested in mouse models to answer essential questions for the successful translation of our novel, function-based approach.